Vor Biopharma (VOR) Short-term Investments (2021 - 2026)
Vor Biopharma's Short-term Investments came in at $358.27 million for Q2 2026, compared with $9.99 million a year earlier and up 11.4% from the prior quarter.
Powered by 
Analysis
Vor Biopharma (VOR) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Vor Biopharma's Short-term Investments was $58.72 million, up 488.6% from FY2024.
- Short-term Investments carries a four-year compound annual growth rate of -9.5% (FY2021 to FY2025).
- Going back by year, Short-term Investments was $9.98 million in FY2024 (-90.6%), $105.82 million in FY2023 (-38.7%), $172.54 million in FY2022 (+96.8%) and $87.67 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Short-term Investments in data going back to Q2 2021.
- Year-over-year, Short-term Investments increased in two of the last six quarters, with growth averaging 37.3%.
- The fastest year-over-year change in Short-term Investments over five years came in Q4 2025 (growth of 488.6%), and the weakest in Q2 2024 (a decline of 93.6%).
- Business Quant data shows VOR's Short-term Investments at $321.65 million (Q1 2026), $58.72 million (Q4 2025) and $10 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Vor Biopharma | 1.03 Bn | -551.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 358.27 Mn |
| Mar 31, 2026 | 321.65 Mn |
| Dec 31, 2025 | 58.72 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 9.99 Mn |
| Mar 31, 2025 | 9.99 Mn |
| Dec 31, 2024 | 9.98 Mn |
| Sep 30, 2024 | 10.01 Mn |
| Jun 30, 2024 | 9.86 Mn |
| Mar 31, 2024 | 62.52 Mn |
| Dec 31, 2023 | 105.82 Mn |
| Sep 30, 2023 | 115.07 Mn |
| Jun 30, 2023 | 154.69 Mn |
| Mar 31, 2023 | 167.75 Mn |
| Dec 31, 2022 | 172.54 Mn |
| Sep 30, 2022 | 75.24 Mn |
| Jun 30, 2022 | 88.14 Mn |
| Mar 31, 2022 | 91.58 Mn |
| Dec 31, 2021 | 87.67 Mn |
| Sep 30, 2021 | 82.93 Mn |
API Access
Vor Biopharma Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=VOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "VOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=VOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();